Caspase Recruitment Domain Family Member 8: A Favorable Target in the Pathogenesis of Atherosclerosis

Atherosclerosis, a lipid-driven chronic inflammatory disease, is the primary pathological basis of cardiovascular diseases, characterized by endothelial injury, lipid deposition, immune cell infiltration, and chronic inflammation. The NOD-like Receptor Pyrin Domain-Containing 3 (NLRP3) inflammasome has emerged as a crucial mediator of inflammation in atherosclerosis, with caspase recruitment domain family member 8 (CARD8) acting as a key regulatory component. Indeed, CARD8, a member of the caspase recruitment domain family, regulates immune responses by modulating inflammasome activity, particularly NLRP3. Recent studies suggest that CARD8 influences various aspects of atherosclerotic development, including lipid accumulation, oxidative stress, vascular inflammation, smooth muscle cell proliferation, and plaque instability. Thus, this review summarizes the latest findings on the role of CARD8 in the pathogenesis of atherosclerosis, with a focus on the regulatory effects of this component on immune cells and inflammatory pathways. We also discuss the potential of targeting CARD8 as a therapeutic strategy for atherosclerosis, exploring the current preclinical and clinical evidence.

• Publication year

  2026

• Venue

  Reviews in cardiovascular medicine

• Publication date

  2026-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.31083/RCM44518PMID 41659085PMCID 12873704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Atherosclerotic plaque stabilization and regression: a review of clinical evidence

  2024cited by this paper
• Regulatory T cells in immune checkpoint blockade antitumor therapy

  2024cited by this paper
• The hydrophobicity of the CARD8 N-terminus tunes inflammasome activation.

  2024cited by this paper
• CARD8: A Novel Inflammasome Sensor with Well-Known Anti-Inflammatory and Anti-Apoptotic Activity

  2024influential reference
• CNP Ameliorates Macrophage Inflammatory Response and Atherosclerosis

  2024cited by this paper
• The CARD8 inflammasome dictates HIV/SIV pathogenesis and disease progression.

  2024cited by this paper
• Association between C10X polymorphism in the CARD8 gene and inflammatory markers in young healthy individuals in the LBA study

  2024influential reference
• Hegemony of inflammation in atherosclerosis and coronary artery disease.

  2024cited by this paper
• Regulatory T cells and cardiovascular diseases

  2023cited by this paper
• Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis

  2023cited by this paper
• Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets

  2023cited by this paper
• Primary Prevention of Subclinical Atherosclerosis in Young Adults: JACC Review Topic of the Week.

  2023cited by this paper
• Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis.

  2023cited by this paper
• Trimethylamine N-oxide promotes oxidative stress and lipid accumulation in macrophage foam cells via the Nrf2/ABCA1 pathway

  2023cited by this paper
• The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases

  2023cited by this paper
• Different types of cell death in diabetic endothelial dysfunction.

  2023cited by this paper
• BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis

  2023cited by this paper
• Impact of Lipid Metabolism on Macrophage Polarization: Implications for Inflammation and Tumor Immunity

  2023cited by this paper
• Inflammasomes: Mechanisms of Action and Involvement in Human Diseases

  2023cited by this paper
• Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis.

  2023cited by this paper
• Inflammasomes and Atherosclerosis: a Mixed Picture.

  2023cited by this paper
• Nicotine exacerbates atherosclerosis and plaque instability via NLRP3 inflammasome activation in vascular smooth muscle cells

  2023cited by this paper
• NLRP3 inflammasome-driven IL-1β and IL-18 contribute to lipopolysaccharide-induced septic cardiomyopathy.

  2023cited by this paper
• Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

  2023cited by this paper
• The exoprotein Gbp of Fusobacterium nucleatum promotes THP-1 cell lipid deposition by binding to CypA and activating PI3K-AKT/MAPK/NF-κB pathways

  2023cited by this paper
• Colchicine exerts anti‐atherosclerotic and ‑plaque‐stabilizing effects targeting foam cell formation

  2023cited by this paper
• Association between NLRP3 rs10754558 and CARD8 rs2043211 Variants and Susceptibility to Chronic Kidney Disease

  2023cited by this paper
• The Role of Macrophages in the Pathogenesis of Atherosclerosis

  2023cited by this paper
• Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction

  2023cited by this paper
• Protein folding stress potentiates NLRP1 and CARD8 inflammasome activation.

  2023cited by this paper
• The emerging role of Th1 cells in atherosclerosis and its implications for therapy

  2023cited by this paper
• Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells

  2023cited by this paper
• Molecular Mechanisms Underlying Pathological and Therapeutic Roles of Pericytes in Atherosclerosis

  2022cited by this paper
• Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning

  2022cited by this paper
• Viral proteases activate the CARD8 inflammasome in the human cardiovascular system

  2022cited by this paper
• A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA

  2022cited by this paper
• S1PR2/RhoA/ROCK1 pathway promotes inflammatory bowel disease by inducing intestinal vascular endothelial barrier damage and M1 macrophage polarization.

  2022cited by this paper
• Pnpt1 mediates NLRP3 inflammasome activation by MAVS and metabolic reprogramming in macrophages

  2022cited by this paper
• A Novel Peptide Isolated from Microalgae Isochrysis zhanjiangensis Exhibits Anti-apoptosis and Anti-inflammation in Ox-LDL Induced HUVEC to Improve Atherosclerosis

  2022cited by this paper
• Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

  2022cited by this paper
• Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms

  2022cited by this paper
• Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation

  2022cited by this paper
• Macrophages: shapes and functions

  2022cited by this paper
• Silica nanoparticles induce pyroptosis and cardiac hypertrophy via ROS/NLRP3/Caspase-1 pathway.

  2022cited by this paper
• Autophagy in Atherosclerotic Plaque Cells: Targeting NLRP3 Inflammasome for Self-Rescue

  2022cited by this paper
• Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation.

  2022cited by this paper
• Atherosclerosis and Endothelial Mechanotransduction: Current Knowledge and Models for Future Research.

  2022cited by this paper
• Macrophage-, Dendritic-, Smooth Muscle-, Endothelium-, and Stem Cells-Derived Foam Cells in Atherosclerosis

  2022cited by this paper
• A myriad of roles of dendritic cells in atherosclerosis

  2021cited by this paper
• Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment.

  2021cited by this paper
• Structural basis for distinct inflammasome complex assembly by human NLRP1 and CARD8

  2021cited by this paper
• Targeting inflammation in atherosclerosis — from experimental insights to the clinic

  2021cited by this paper
• NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer

  2021cited by this paper
• An update on the regulatory mechanisms of NLRP3 inflammasome activation

  2021cited by this paper
• Functional Role of B Cells in Atherosclerosis

  2021cited by this paper
• CARD8 is an inflammasome sensor for HIV-1 protease activity

  2021cited by this paper
• NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis

  2021cited by this paper
• Targeting the NLRP3 inflammasome in cardiovascular diseases.

  2021cited by this paper
• Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis

  2021cited by this paper
• Mechanism of filament formation in UPA-promoted CARD8 and NLRP1 inflammasomes

  2021cited by this paper
• OUP accepted manuscript

  2021cited by this paper
• The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages

  2021cited by this paper
• Oxidized LDL-regulated microRNAs for evaluating vascular endothelial function: molecular mechanisms and potential biomarker roles in atherosclerosis

  2021cited by this paper
• Deletion of Fam172a accelerates advanced atherosclerosis and induces plaque instability.

  2021cited by this paper
• How the immune system shapes atherosclerosis: roles of innate and adaptive immunity

  2021cited by this paper
• Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq.

  2021cited by this paper
• NLRP3 inflammasome activation and cell death

  2021cited by this paper
• Genetic Polymorphisms of NLRP3 (rs4612666) and CARD8 (rs2043211) in Periodontitis and Cardiovascular Diseases

  2021cited by this paper
• Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950

  2021cited by this paper
• Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events.

  2020cited by this paper
• T cell subsets and functions in atherosclerosis

  2020cited by this paper
• Plasma Levels of TMAO can be Increased with 'Healthy' and 'Unhealthy' Diets and Do Not Correlate with the Extent of Atherosclerosis but with Plaque Instability.

  2020cited by this paper
• Regulation of NLRP3 inflammasome by CD38 through cADPR-mediated Ca2+ release in vascular smooth muscle cells in diabetic mice.

  2020cited by this paper
• The NLRP1 and CARD8 inflammasomes

  2020influential reference
• Structural basis for distinct inflammasome complex assembly by human NLRP1 and CARD8

  2020cited by this paper
• Inflammasomes.

  2020cited by this paper
• Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead

  2020cited by this paper
• Immunogenetics of Atherosclerosis—Link between Lipids, Immunity, and Genes

  2020cited by this paper
• Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations

  2020cited by this paper
• CARD8 inflammasome activation triggers pyroptosis in human T cells

  2020influential reference
• NLRP3 inflammasome in endothelial dysfunction

  2020cited by this paper
• Activation of the CARD8 Inflammasome Requires a Disordered Region

  2020cited by this paper
• Expression of CARD8 in human atherosclerosis and its regulation of inflammatory proteins in human endothelial cells

  2020influential reference
• Mechanism overview and target mining of atherosclerosis: Endothelial cell injury in atherosclerosis is regulated by glycolysis (Review)

  2020cited by this paper
• Regulatory T Cell Stability and Plasticity in Atherosclerosis

  2020cited by this paper
• CXCR4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis.

  2020cited by this paper
• Long Noncoding RNAs of the Arterial Wall as Therapeutic Agents and Targets in Atherosclerosis

  2019cited by this paper
• The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

  2019cited by this paper
• Vascular smooth muscle cells in atherosclerosis

  2019cited by this paper
• Smooth Muscle Cell Phenotypic Diversity.

  2019cited by this paper
• Pharmacological Inhibitors of the NLRP3 Inflammasome

  2019cited by this paper
• Transcriptional and epigenetic regulation of macrophages in atherosclerosis

  2019cited by this paper
• Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

  2019cited by this paper
• DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages

  2019cited by this paper
• Immunity and Inflammation in Atherosclerosis

  2019cited by this paper
• Genetic Profiling of Aspergillus Isolates with Varying Aflatoxin Production Potential from Different Maize-Growing Regions of Kenya

  2019cited by this paper
• From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review.

  2019cited by this paper
• Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome

  2019cited by this paper
• Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy.

  2019cited by this paper
• Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series.

  2018cited by this paper

• No citing papers are available for this paper.